Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction


Tartan Z., Ozer N., Uyarel H., Akgul O., Gul M., ÇETİN M., ...Daha Fazla

Nutrition, Metabolism and Cardiovascular Diseases, cilt.18, sa.6, ss.441-447, 2008 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 6
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.numecd.2007.02.015
  • Dergi Adı: Nutrition, Metabolism and Cardiovascular Diseases
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.441-447
  • Anahtar Kelimeler: metabolic syndrome, no-reflow phenomenon, ST-segment, resolution, primary coronary intervention
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background and aim: The purpose of this study was to evaluate both the predictive value of metabolic syndrome (MS) on no-reflow phenomenon and 30-day clinical outcomes on patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). Methods and results: One hundred and twelve consecutive patients (mean age 57 ± 11 years, 94 male) with acute STEMI treated with primary PCI were analysed prospectively. Sum of ST-segment elevation was obtained immediately before and 60 min after the restoration of TIMI-3 flow. The difference between two measurements was accepted as the amount of ST-segment resolution and was expressed as ∑STR. ∑STR < 50% was accepted as ECG sign of no-reflow phenomenon. Metabolic syndrome was defined based on Adult Treatment Panel-III criteria. The no-reflow was found in 22.3% of the entire group and was significantly higher in patients with MS than those without MS (43.7% vs. 13.7%, p < 0.001). There was no significant difference in no-reflow between patients who had both MS and diabetes mellitus (DM) and patients who had MS but not DM (42.5% vs. 50%, respectively; p > 0.05). Conclusion: The presence of MS may play an important role in the occurrence of no- reflow in STEMI treated with primary PCI. © 2007 Elsevier B.V. All rights reserved.